Malmström H - Search Results

1

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

Reed NS, Mangioni C, Malmström H, Scarfone G, Poveda A, Pecorelli S, Tateo S, Franchi M, Jobsen JJ, Coens C, Teodorovic I, Vergote I, Vermorken JB; European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group. Reed NS, et al. Among authors: malmstrom h. Eur J Cancer. 2008 Apr;44(6):808-18. doi: 10.1016/j.ejca.2008.01.019. Epub 2008 Apr 2. Eur J Cancer. 2008. PMID: 18378136 Clinical Trial.

2

A phase II study of intraperitoneal carboplatin as adjuvant treatment in early-stage ovarian cancer patients.

Malmström H, Simonsen E, Westberg R. Malmström H, et al. Gynecol Oncol. 1994 Jan;52(1):20-5. doi: 10.1006/gyno.1994.1005. Gynecol Oncol. 1994. PMID: 8307496 Clinical Trial.

3

Granulosa cell tumors of the ovary: prognostic factors and outcome.

Malmström H, Högberg T, Risberg B, Simonsen E. Malmström H, et al. Gynecol Oncol. 1994 Jan;52(1):50-5. doi: 10.1006/gyno.1994.1010. Gynecol Oncol. 1994. PMID: 8307501

4

Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.

Malmström H, Schmidt H, Persson PG, Carstensen J, Nordenskjöld B, Simonsen E. Malmström H, et al. Gynecol Oncol. 1992 Feb;44(2):172-7. doi: 10.1016/0090-8258(92)90034-g. Gynecol Oncol. 1992. PMID: 1544595

5

Invasive cancer of the vulva.

Rosén C, Malmström H. Rosén C, et al. Among authors: malmstrom h. Gynecol Oncol. 1997 May;65(2):213-7. doi: 10.1006/gyno.1997.4662. Gynecol Oncol. 1997. PMID: 9159327

6

Phase I study of intraperitoneal carboplatin as adjuvant therapy in early ovarian cancer.

Malmström H, Larsson D, Simonsen E. Malmström H, et al. Gynecol Oncol. 1990 Dec;39(3):289-94. doi: 10.1016/0090-8258(90)90254-i. Gynecol Oncol. 1990. PMID: 2258073

7

Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer.

Malmström H, Carstensen J, Simonsen E. Malmström H, et al. Gynecol Oncol. 1994 Jul;54(1):27-34. doi: 10.1006/gyno.1994.1161. Gynecol Oncol. 1994. PMID: 8020835

8

Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.

Malmström H, Rasmussen S, Simonsen E. Malmström H, et al. Gynecol Oncol. 1993 May;49(2):166-71. doi: 10.1006/gyno.1993.1101. Gynecol Oncol. 1993. PMID: 8504983 Clinical Trial.

9

Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.

Blom R, Guerrieri C, Stâl O, Malmström H, Sullivan S, Simonsen E. Blom R, et al. Among authors: malmstrom h. Gynecol Oncol. 1998 Jan;68(1):18-24. doi: 10.1006/gyno.1997.4892. Gynecol Oncol. 1998. PMID: 9454654

10

Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.

Blom R, Guerrieri C, Stâl O, Malmström H, Simonsen E. Blom R, et al. Among authors: malmstrom h. Gynecol Oncol. 1998 Jan;68(1):54-61. doi: 10.1006/gyno.1997.4889. Gynecol Oncol. 1998. PMID: 9454661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page